{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:31:44Z","timestamp":1794583904553,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"national institutes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02054-8","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:04:15Z","timestamp":1769238255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson\u2019s disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Anna E.","family":"Goodheart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hyeon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Fassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewodros M.","family":"Dagnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Striar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moqing","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Rattray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler N.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Peterec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ying","family":"Wey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Gomperts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"6","key":"2054_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn.2017.46","volume":"18","author":"JY Hwang","year":"2017","unstructured":"Hwang JY, Aromolaran KA, Zukin RS. The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat Rev Neurosci. 2017;18(6):347\u201361.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2054_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","volume":"66","author":"Z Konsoula","year":"2012","unstructured":"Konsoula Z, Barile FA. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. J Pharmacol Toxicol Methods. 2012;66(3):215\u201320.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"2054_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nn.3302","volume":"16","author":"KM Lattal","year":"2013","unstructured":"Lattal KM, Wood MA. Epigenetics and persistent memory: implications for reconsolidation and silent extinction beyond the zero. Nat Neurosci. 2013;16(2):124\u20139.","journal-title":"Nat Neurosci"},{"issue":"2","key":"2054_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","volume":"31","author":"SC McQuown","year":"2011","unstructured":"McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, et al. HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci. 2011;31(2):764\u201374.","journal-title":"J Neurosci"},{"issue":"5979","key":"2054_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.1186088","volume":"328","author":"S Peleg","year":"2010","unstructured":"Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science. 2010;328(5979):753\u20136.","journal-title":"Science"},{"issue":"355","key":"2054_CR6","doi-asserted-by":"publisher","first-page":"re12","DOI":"10.1126\/scisignal.aaa0069","volume":"7","author":"J Penney","year":"2014","unstructured":"Penney J, Tsai LH. Histone deacetylases in memory and cognition. Sci Signal. 2014;7(355):re12.","journal-title":"Sci Signal"},{"issue":"7","key":"2054_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.it.2011.04.001","volume":"32","author":"MR Shakespear","year":"2011","unstructured":"Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011;32(7):335\u201343.","journal-title":"Trends Immunol"},{"key":"2054_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2020.00537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL. Histone deacetylases inhibitors in neurodegenerative Diseases, neuroprotection and neuronal differentiation. Front Pharmacol. 2020;11:537.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2054_CR9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, et al. HDAC3 negatively regulates Spatial memory in a mouse model of alzheimer\u2019s disease. Aging Cell. 2017;16(5):1073\u201382.","journal-title":"Aging Cell"},{"issue":"7243","key":"2054_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009;459(7243):55\u201360.","journal-title":"Nature"},{"issue":"16","key":"2054_CR11","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1111\/bph.13208","volume":"172","author":"IF Harrison","year":"2015","unstructured":"Harrison IF, Crum WR, Vernon AC, Dexter DT. Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of parkinson\u2019s is associated with histone acetylation and up-regulation of neurotrophic factors. Br J Pharmacol. 2015;172(16):4200\u201315.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2054_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","volume":"140","author":"IF Harrison","year":"2013","unstructured":"Harrison IF, Dexter DT. Epigenetic targeting of histone deacetylase: therapeutic potential in parkinson\u2019s disease? Pharmacol Ther. 2013;140(1):34\u201352.","journal-title":"Pharmacol Ther"},{"issue":"11","key":"2054_CR13","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4103\/1673-5374.194803","volume":"11","author":"SV Hegarty","year":"2016","unstructured":"Hegarty SV, Sullivan AM, O\u2019Keeffe GW. The epigenome as a therapeutic target for parkinson\u2019s disease. Neural Regen Res. 2016;11(11):1735\u20138.","journal-title":"Neural Regen Res"},{"key":"2054_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuroscience.2011.08.010","volume":"194","author":"SK Kidd","year":"2011","unstructured":"Kidd SK, Schneider JS. Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of parkinson\u2019s disease. Neuroscience. 2011;194:189\u201394.","journal-title":"Neuroscience"},{"issue":"4","key":"2054_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of alzheimer\u2019s disease. Neuropsychopharmacology. 2010;35(4):870\u201380.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"2054_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5607\/en.2019.28.4.504","volume":"28","author":"T Kim","year":"2019","unstructured":"Kim T, Song S, Park Y, Kang S, Seo H. HDAC Inhibition by valproic acid induces neuroprotection and improvement of PD-like behaviors in LRRK2 R1441G Transgenic mice. Exp Neurobiol. 2019;28(4):504\u201315.","journal-title":"Exp Neurobiol"},{"issue":"4","key":"2054_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-016-1590-9","volume":"132","author":"C Labbe","year":"2016","unstructured":"Labbe C, Lorenzo-Betancor O, Ross OA. Epigenetic regulation in parkinson\u2019s disease. Acta Neuropathol. 2016;132(4):515\u201330.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2054_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","volume":"17","author":"B Monti","year":"2010","unstructured":"Monti B, Gatta V, Piretti F, Raffaelli SS, Virgili M, Contestabile A. Valproic acid is neuroprotective in the rotenone rat model of parkinson\u2019s disease: involvement of alpha-synuclein. Neurotox Res. 2010;17(2):130\u201341.","journal-title":"Neurotox Res"},{"issue":"5837","key":"2054_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of parkinson\u2019s disease. Science. 2007;317(5837):516\u20139.","journal-title":"Science"},{"issue":"1","key":"2054_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","volume":"134","author":"GS Peng","year":"2005","unstructured":"Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, et al. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Brain Res Mol Brain Res. 2005;134(1):162\u20139.","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"2054_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s42003-023-05725-x","volume":"7","author":"P Reho","year":"2024","unstructured":"Reho P, Saez-Atienzar S, Ruffo P, Solaiman S, Shah Z, Chia R, et al. Differential methylation analysis in neuropathologically confirmed dementia with lewy bodies. Commun Biol. 2024;7(1):35.","journal-title":"Commun Biol"},{"key":"2054_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neurobiolaging.2018.02.018","volume":"68","author":"Y Tan","year":"2018","unstructured":"Tan Y, Delvaux E, Nolz J, Coleman PD, Chen S, Mastroeni D. Upregulation of histone deacetylase 2 in laser capture nigral microglia in parkinson\u2019s disease. Neurobiol Aging. 2018;68:134\u201341.","journal-title":"Neurobiol Aging"},{"key":"2054_CR23","first-page":"313702","volume":"2015","author":"JC Ximenes","year":"2015","unstructured":"Ximenes JC, Neves KR, Leal LK, do Carmo MR, Brito GA, Naffah-Mazzacoratti Mda G, et al. Valproic acid neuroprotection in the 6-OHDA model of parkinson\u2019s disease is possibly related to its Anti-Inflammatory and HDAC inhibitory properties. J Neurodegener Dis. 2015;2015:313702.","journal-title":"J Neurodegener Dis"},{"key":"2054_CR24","doi-asserted-by":"publisher","first-page":"143269","DOI":"10.1155\/2011\/143269","volume":"2011","author":"K Xu","year":"2011","unstructured":"Xu K, Dai XL, Huang HC, Jiang ZF. Targeting hdacs: a promising therapy for alzheimer\u2019s disease. Oxid Med Cell Longev. 2011;2011:143269.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"2054_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbadis.2018.11.014","volume":"1865","author":"AR Esteves","year":"2019","unstructured":"Esteves AR, Palma AM, Gomes R, Santos D, Silva DF, Cardoso SM. Acetylation as a major determinant to microtubule-dependent autophagy: relevance to alzheimer\u2019s and Parkinson disease pathology. Biochim Biophys Acta Mol Basis Dis. 2019;1865(8):2008\u201323.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2054_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","volume":"666","author":"IF Harrison","year":"2018","unstructured":"Harrison IF, Smith AD, Dexter DT. Pathological histone acetylation in parkinson\u2019s disease: neuroprotection and Inhibition of microglial activation through SIRT 2 Inhibition. Neurosci Lett. 2018;666:48\u201357.","journal-title":"Neurosci Lett"},{"issue":"4","key":"2054_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cns.12217","volume":"20","author":"M Zhu","year":"2014","unstructured":"Zhu M, Li WW, Lu CZ. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. CNS Neurosci Ther. 2014;20(4):308\u201316.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"2054_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-021-00450-7","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker L, Tran GT, Sundaresan J, Tysnes OB, Alves G, Haugarvoll K, et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the parkinson\u2019s disease brain. Mol Neurodegener. 2021;16(1):31.","journal-title":"Mol Neurodegener"},{"key":"2054_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","volume":"627","author":"KG Gebremedhin","year":"2016","unstructured":"Gebremedhin KG, Rademacher DJ. Histone H3 acetylation in the postmortem parkinson\u2019s disease primary motor cortex. Neurosci Lett. 2016;627:121\u20135.","journal-title":"Neurosci Lett"},{"issue":"20","key":"2054_CR30","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","volume":"15","author":"E Kontopoulos","year":"2006","unstructured":"Kontopoulos E, Parvin JD, Feany MB. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet. 2006;15(20):3012\u201323.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2054_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/089198870201500406","volume":"15","author":"DW Dickson","year":"2002","unstructured":"Dickson DW. Dementia with lewy bodies: neuropathology. J Geriatr Psychiatry Neurol. 2002;15(4):210\u20136.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2054_CR32","unstructured":"Irwin DJ, Hurtig HI. The contribution of Tau, Amyloid-Beta and Alpha-Synuclein pathology to dementia in lewy body disorders. J Alzheimers Dis Parkinsonism. 2018;8(4)."},{"issue":"12","key":"2054_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, et al. Imaging amyloid deposition in lewy body diseases. Neurology. 2008;71(12):903\u201310.","journal-title":"Neurology"},{"issue":"2","key":"2054_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"2 Dementia","key":"2054_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/CON.0000000000000309","volume":"22","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN. Lewy body dementias: dementia with lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn). 2016;22(2 Dementia):435\u201363.","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"2054_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM. Cortical lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 2001;102(4):355\u201363.","journal-title":"Acta Neuropathol"},{"issue":"19","key":"2054_CR37","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1021\/jm500872p","volume":"57","author":"C Wang","year":"2014","unstructured":"Wang C, Schroeder FA, Wey HY, Borra R, Wagner FF, Reis S, et al. In vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs. J Med Chem. 2014;57(19):7999\u20138009.","journal-title":"J Med Chem"},{"issue":"5","key":"2054_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1021\/acschemneuro.5b00066","volume":"6","author":"HY Wey","year":"2015","unstructured":"Wey HY, Wang C, Schroeder FA, Logan J, Price JC, Hooker JM. Kinetic analysis and quantification of [(1)(1)C]Martinostat for in vivo HDAC imaging of the brain. ACS Chem Neurosci. 2015;6(5):708\u201315.","journal-title":"ACS Chem Neurosci"},{"issue":"351","key":"2054_CR39","doi-asserted-by":"publisher","first-page":"351ra106","DOI":"10.1126\/scitranslmed.aaf7551","volume":"8","author":"HY Wey","year":"2016","unstructured":"Wey HY, Gilbert TM, Zurcher NR, She A, Bhanot A, Taillon BD, et al. Insights into neuroepigenetics through human histone deacetylase PET imaging. Sci Transl Med. 2016;8(351):351ra106.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2054_CR40","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1038\/s41467-022-30653-5","volume":"13","author":"TA Pascoal","year":"2022","unstructured":"Pascoal TA, Chamoun M, Lax E, Wey HY, Shin M, Ng KP, et al. [(11)C]Martinostat PET analysis reveals reduced HDAC I availability in alzheimer\u2019s disease. Nat Commun. 2022;13(1):4171.","journal-title":"Nat Commun"},{"issue":"5","key":"2054_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord. 2003;18(5):467\u201386.","journal-title":"Mov Disord"},{"issue":"12","key":"2054_CR42","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with parkinson\u2019s disease. Mov Disord. 2007;22(12):1689\u2013707. quiz 837.","journal-title":"Mov Disord"},{"issue":"1","key":"2054_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"17","key":"2054_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with lewy bodies. Neurology. 2020;94(17):743\u201355.","journal-title":"Neurology"},{"issue":"15","key":"2054_CR45","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement disorder Society-sponsored revision of the unified parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370.","journal-title":"Mov Disord"},{"issue":"5","key":"2054_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427\u201342.","journal-title":"Neurology"},{"issue":"4","key":"2054_CR47","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive Assessment, moca: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2054_CR48","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31(3):968\u201380.","journal-title":"NeuroImage"},{"issue":"3","key":"2054_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341\u201355.","journal-title":"Neuron"},{"issue":"1","key":"2054_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cercor\/bhg087","volume":"14","author":"B Fischl","year":"2004","unstructured":"Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14(1):11\u201322.","journal-title":"Cereb Cortex"},{"issue":"Suppl 1","key":"2054_CR51","doi-asserted-by":"publisher","first-page":"A57","DOI":"10.1186\/2197-7364-1-S1-A57","volume":"1","author":"DB Chonde","year":"2014","unstructured":"Chonde DB, Izquierdo-Garcia D, Chen K, Bowen SL, Catana C. Masamune: a tool for automatic dynamic PET data processing, image reconstruction and integrated PET\/MRI data analysis. EJNMMI Phys. 2014;1(Suppl 1):A57.","journal-title":"EJNMMI Phys"},{"key":"2054_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C, et al. Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging. NeuroImage. 2016;132:334\u201343.","journal-title":"NeuroImage"},{"issue":"11","key":"2054_CR53","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA. Incidence of dementia with lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013;70(11):1396\u2013402.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2054_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of alzheimer\u2019s disease. Alzheimers Dement. 2012;8(1):1\u201313.","journal-title":"Alzheimers Dement"},{"key":"2054_CR55","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.nicl.2015.06.001","volume":"8","author":"A Rieckmann","year":"2015","unstructured":"Rieckmann A, Gomperts SN, Johnson KA, Growdon JH, Van Dijk KR. Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with lewy body diseases. Neuroimage Clin. 2015;8:554\u20139.","journal-title":"Neuroimage Clin"},{"issue":"12","key":"2054_CR56","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00702-023-02688-5","volume":"130","author":"K Kinugawa","year":"2023","unstructured":"Kinugawa K, Mano T, Fujimura S, Takatani T, Miyasaka T, Sugie K. Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in parkinson\u2019s disease. J Neural Transm (Vienna). 2023;130(12):1537\u201345.","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"2054_CR57","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/hbm.21118","volume":"32","author":"T Wu","year":"2011","unstructured":"Wu T, Long X, Wang L, Hallett M, Zang Y, Li K, et al. Functional connectivity of cortical motor areas in the resting state in parkinson\u2019s disease. Hum Brain Mapp. 2011;32(9):1443\u201357.","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"2054_CR58","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41467-019-11031-0","volume":"10","author":"TM Gilbert","year":"2019","unstructured":"Gilbert TM, Zurcher NR, Catanese MC, Tseng CJ, Di Biase MA, Lyall AE, et al. Neuroepigenetic signatures of age and sex in the living human brain. Nat Commun. 2019;10(1):2945.","journal-title":"Nat Commun"},{"key":"2054_CR59","doi-asserted-by":"crossref","unstructured":"Yoo CH, Rani N, Shen S, Loggia ML, Gaynor K, Moore KE et al. Investigating neuroepigenetic alterations in chronic low back pain with positron emission tomography. Pain. 2024.","DOI":"10.1097\/j.pain.0000000000003272"},{"issue":"7","key":"2054_CR60","doi-asserted-by":"publisher","first-page":"110159","DOI":"10.1016\/j.isci.2024.110159","volume":"27","author":"TM Dagnew","year":"2024","unstructured":"Dagnew TM, Tseng CJ, Yoo CH, Makary MM, Goodheart AE, Striar R, et al. Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: a proof-of-concept study. iScience. 2024;27(7):110159.","journal-title":"iScience"},{"issue":"4","key":"2054_CR61","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","volume":"89","author":"G Rizzo","year":"2018","unstructured":"Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, et al. Accuracy of clinical diagnosis of dementia with lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89(4):358\u201366.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02054-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02054-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02054-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:03:34Z","timestamp":1771329814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02054-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02054-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6647341\/v1","asserted-by":"object"}]},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Mass General Brigham Institutional Review Board. All participants provided informed consent or, in the event of incapacity to provide consent due to dementia, assent with consent provided by a designated study partner; informed consent procedures adhered to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CW and JMH are inventors of the [11\u00a0C]Martinostat epigenetic PET radiotracer imaging probe used in this project.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}